solanine has been researched along with Colorectal Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| An, HM; Chen, L; Hu, B; Li, M; Peng, X; Que, ZJ; Shen, KP; Yan, X | 1 |
| Chen, J; Hu, Z; Jiang, L; Lu, F; Ni, X; Xu, X; Yuan, Z | 1 |
2 other study(ies) available for solanine and Colorectal Neoplasms
| Article | Year |
|---|---|
α‑Solanine inhibits growth and metastatic potential of human colorectal cancer cells.
Topics: Animals; Antineoplastic Agents; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colorectal Neoplasms; Cyclin D1; Cyclin-Dependent Kinase 2; Dose-Response Relationship, Drug; Down-Regulation; Gene Expression Regulation, Neoplastic; HCT116 Cells; Humans; Male; Mice; Neoplasm Metastasis; Solanine; Time Factors; Xenograft Model Antitumor Assays | 2020 |
Anti-Cancer Effect of α-Solanine by Down-Regulating S100P Expression in Colorectal Cancer Cells.
Topics: Animals; Antineoplastic Agents; Calcium-Binding Proteins; Cell Line, Tumor; Colorectal Neoplasms; Down-Regulation; Gene Expression Regulation, Neoplastic; HT29 Cells; Humans; Mice; Mice, Nude; Neoplasm Proteins; Solanine; Treatment Outcome; Tumor Burden; Xenograft Model Antitumor Assays | 2018 |